71 results about "Herba Scutellaria Barbata" patented technology

The invention provides detoxification strengthening powder for treating chronic viral hepatitis B, which comprises the following components in parts by weight: 15-25 parts of vinegar radix bupleuri, 15-25 parts of honey-fried licorice root, 60-75 parts of poria cocos, 60-75 parts of rhizoma atractylodis macrocephalae, 60-75 parts of radix paeoniae alba, 30-50 parts of angelica sinensis, 85-100 parts of honeysuckle flower, 80-100 parts of sculellaria barbata, 60-75 parts of raw astragalus membranaceus, 90-100 parts of the root of red-rooted salvia, 80-100 parts of raw barley, 30-45 parts of schisandra chinensis, 35-50 parts of the root bark of the peony tree, 35-50 parts of medlar and 30-50 parts of glossy privet fruit. By adopting multi-directional, multi-target and multi-link comprehensive treatment according to multiple complex mechanisms of diseases, the composition provided by the invention has the functions of balancing yin and yang and regulating the qi and blood of the chronic hepatitis B patients, so that the chronic hepatitis B patients have full healthy atmosphere, and the pathogenic factors can be removed. Each single medicine is not powerful; the components have different effects, for example, the honeysuckle flower can clear away heat and toxic materials but cannot replace angelica sinensis to nourish and regulate blood, and even more, the honeysuckle flower does not have the effect of medlar for nourishing liver and kidney. Each medicine should be reasonably combined with other medicines, so that both symptoms and root causes can be resolved, and a more remarkable clinical treatment effect can be obtained.

The invention discloses a medicine for treating ascites due to liver cancer. The medicine comprises the following components in parts by weight: 15-19 parts of radix bupleuri, 15-19 parts of bighead atractylodes rhizome, 20-24 parts of white peony root, 15-19 parts of dried tangerine peel, 10-14 parts of chrysanthemum morifolium, 10-14 parts of Chinese angelica, 15-19 parts of salviae miltiorrhizae, 20-24 pats of fiveleaf akebia fruit, 5-9 parts of safflower, 15-19 parts of poria, 20-24 parts of sculellaria barbata, 20-24 parts of rhizoma sparganic, 30-34 parts of polygonum cuspidatum, 10-14 parts of moutan bark, 20-24 parts of dandelion, 20-24 parts of solanum nigrum, 20-24 parts of oriental wormwood, 20-24 parts of curcuma zedoary, 20-24 parts of aspongopus, 20-24 parts of indian iphigenia bulb, 10-14 parts of spina gleditsiae, 20-24 parts of manyleaf paris rhizome, 10-14 parts of fructus aurantii, 15-19 parts of artemisia anomala, 20-24 parts of raw oyster, 20-24 parts of turtle shell, 10-14 parts of costustoot, 15-19 parts of codonopsis pilosula, 30-34 parts of selfheal, 15-19 parts of salvia chinensis, 15-19 parts of verbena, 5-9 parts of rhizoma alismatis, 5-9 parts of polyporus umbellatus, 10-14 parts of plantain seed, 10-14 parts of frankincense, 10-14 parts of myrrh, 10-14 parts of corydalis tuber, 10-14 parts of radix curcumae, 10-14 parts of toad skin, 5-9 parts of greater celandine herb, 5-9 parts of szechwan Chinaberry fruit, 10-14 parts of sappanwood, 3-7 parts of radix phytolaccae, 10-14 parts of paniculate swallowwort root, and 3-7 parts of semen pharbitidis. The effective rate of the medicine in treating ascites due to liver cancer can be 73 percent.

The invention discloses a preparation for treating cervical cancer and a preparation method thereof. The preparation is mainly prepared from, by weight, 10-16 parts of white peony root, 8-13 parts of stachys palustris L., 9-14 parts of galium aparine, 7-13 parts of medicine terminalia fruit, 10-15 parts of Balanophora dioica R.Br.ex Royle, 8-16 parts of scutellariae barbatae, 11-15 parts of bauhinia championii, 9-16 parts of conyza japonica, 7-14 parts of dendrobium, 8-14 parts of dysosma versipelis, 6-15 parts of diversifolious patrinia root, 9-13 parts of petrea volubilis, 8-12 parts of patrinia scaniosaefolia, 10-14 parts of hupeh bauhinia root and 9-15 parts of Chinese pulsatilla root. The preparation is safe and reliable, various side effects and sequelae caused by western medicine treatment can be avoided, the immunity of patients can be improved, the cancer resistant ability of the patients themselves is improved, cancer cell metastasis is restrained in time, and complications are effectively reduced.

The invention relates to an anticancer drug, as well as a preparation method and application of the drug. The anticancer drug is prepared by the following raw material drugs in parts by weight: 10-15 parts of radices trichosanthis, 15-25 parts of houttuynia cordata, 30-50 parts of adenophora stricta, 20-50 parts of astragalus mongholicus, 10-25 parts of medlar, 20-50 parts of sculellaria barbata,30-50 parts of wisteria, 20-50 parts of oldenlandia diffusa, 10-15 parts of liquorice and 20-50 parts of paris polyphylla. The invention further provides a method for preparing the anticancer drug and an application in preventing cancer. The anticancer drug provided by the invention has remarkable preventing and curing effects on a plurality of cancers; and the most remarkable characteristic of the anticancer drug is that the cure rate of cancer patients using the drug reaches 10.4% and the overall effective rate is 95%.

The invention relates to a Chinese herbal preparation for treating rectum carcinoma. The preparation comprises the following active pharmaceutical ingredients in parts by weight: 8.95-9.05 parts of cordyceps, 0.03-0.08 part of venenum bufonis, 14.95-15.05 parts of sophora flavescens, 9.95-10.5 parts of pseudobulbus cremastrae seu pleiones, 1.05-2.05 parts of brucea javanica, 11.05-12.05 parts of lithospermum purpurocaeruleum, 49.95-50.05 parts of hedyotis diffusa, 49.95-50.05 parts of scutellaria barbata, 19.95-20.05 parts of golden cypress, 0.25-0.35 part of realgar, 17.95-18.05 parts of mirabilite and 14.95-15.05 parts of liquorice. The Chinese herbal preparation is reasonable in formula, and moreover, the compatible Chinese herbal preparation does not have toxic and side effects, can gradually separate cancer tissues from rectum walls and discharge the cancer tissues out of the body, is simple in preparation method and low in production cost and has an obvious curative effect than conventional curative medicines; the Chinese herbal preparation has a wide treatment application scope, and can be used for treating patients with middle and later periods of cancer, advanced age, weakness or other diseases; and the Chinese herbal preparation has a good treatment effect and a high curative rate, and the survival rate of the operation patients after five years is 50%, and the survival rate of the patients after being treated by the Chinese herbal preparation in five years reaches above 70%.

The invention relates to the field of medicine, and in particular relates to an antineoplastic traditional Chinese medicinal composition. The traditional Chinese medicinal composition is prepared from the following medicinal raw materials in percentage by weight: 10-70% of airpotato yam rhizome and 30-90% of sculellaria barbata; and the traditional Chinese medicinal composition is a whole-powder suspension of the airpotato yam rhizome and the sculellaria barbata, or the traditional Chinese medicinal composition is an ethanol extract with concentration being 20-80%, an ethyl acetate extract, an acetone extract or a gasoline extract. The invention also relates to application of a sculellaria barbata extract and a traditional Chinese medicinal composition of the sculellaria barbata extract, wherein the traditional Chinese medicinal composition consists of the following ingredients: an ethanol extract of airpotato yam rhizome with concentration being 20-80% and an ethanol extract of sculellaria barbata with concentration being 20-80% at a weight ratio of (1-2) to (2-1). The invention also relates to application of scutellarin and a pharmaceutical composition of the scutellarin, wherein the traditional Chinese medicinal composition consists of the following ingredients: diosbulbin B and scutellarin at a weight ratio of (1-1) to (1-2). The pharmaceutical composition can be used for preventing and treating various cancers such as pancreatic cancer, breast cancer, lung cancer, colon cancer and the like.

The invention discloses a drug for preventing and curing avian influenza. The drug is prepared through the steps as follows: firstly, measuring raw materials: measuring the following raw materials in parts by weight: 71-87 parts of astragali radix, 71-87 parts of taraxacum, 71-87 parts of sculellaria barbata, 29-35 parts of glycyrrhiza, 71-87 parts of grassleaf sweelflag rhizome, 71-87 parts of panax ginseng, 72-87 parts of privet leaves, 72-87 parts of folium isatidis, 71-87 parts of horsetail, 72-88 parts of uncaria, 86-106 parts of lotus roots, 71-87 parts of rosa laevigata, 72-88 parts of mentha; secondly, crushing and uniformly mixing the raw materials, and obtaining the drug for preventing and curing avian influenza. According to the invention, the immunity of the poultry uninfected by avian influenza virus such as chickens and ducks can be improved if the drug is taken in advance, and the drug is good in prophylactic effect and has an excellent curing effect on the poultry with the symptoms of avian influenza.

The present invention discloses a scutellaria barbata polysaccharide antitumor mechanism detection research method which comprises the following detecting steps: an in-vivo tumor suppression experiment; ANAE method determination of the total number of T cells in peripheral blood of tumor-bearing mice; flow cytometry determination of T cell subsets and T cell surface protein-CD28 in the peripheral blood of the tumor-bearing mice; and determination of content of IL-2 and IFN-gamma in serum of the peripheral blood of the tumor-bearing mice; the scutellaria barbata polysaccharide in-vivo antitumor and cell immune function influence detection research method discloses a major role of scutellaria barbata polysaccharide in tumor treatment, and meanwhile the study on body cell immune mechanism of plant polysaccharides can be promoted.

The invention discloses sculellaria barbata glycan, an extraction method thereof, and an application of the sculellaria barbata glycan in the preparation of anti-SARS-CoV-2 drugs, and belongs to the technical field of drugs. The method for preparing the sculellaria barbata glycan comprises the following steps: 1, crushing dried sculellaria barbata plants to obtain sculellaria barbata powder; 2, adding deionized water into the sculellaria barbata powder, adjusting the pH value of the sculellaria barbata powder to 4.6-4.8 to obtain a mixed solution, heating the mixed solution to 50-60 DEG C, then adding cellulase, pectinase and papain, and performing enzymolysis for 35-45 min to obtain an enzymolysis solution; 3, heating the enzymolysis solution to 100-110 DEG C, keeping the temperature for1-1.2 hours, and then cooling and filtering to obtain a filtrate; 4, heating and concentrating the filtrate to obtain a concentrated solution, and dialyzing the concentrated solution with flowing water for 2-3 days to obtain a dialysate; 5, heating, concentrating and centrifuging the dialysate, removing obtained precipitate, adding 95% ethanol with the volume 5-6 times that of the obtained supernatant, and standing overnight for out alcohol precipitation to obtain an alcohol precipitation solution; and 6, carrying out centrifugal treatment on the alcohol precipitation solution to obtain a precipitate, and alternately washing the precipitate with absolute ethyl alcohol and acetone for 3-5 times to obtain the sculellaria barbata glycan.

The invention relates to the field of Chinese medicinal preparations, especially a Chinese medicinal composition for treatment of mammary fibroma, a preparation method and application thereof. The composition comprises the following bulk drugs: 5-12 parts by weight of fructus liquidambaris, 3-10 parts by weight of malt, 5-10 parts by weight of radix curcumae, 1-5 parts by weight of centipede, 1-5 parts by weight of toad, 2-8 parts by weight of pangolin, 4-12 parts by weight of Cordyceps, 2-10 parts by weight of Sculellaria barbata, 1-6 parts by weight of ground beetle, 2-8 parts by weight of Ligusticum chuanxiong Hort, 3-10 parts by weight of Cowherb Seed, 2-10 parts by weight of Solanum dulcamara, 2-10 parts by weight of Codonopsis pilosula, 2-10 parts by weight of peach kernel, 3-10 parts by weight of Angelica sinensis, and 2-10 parts by weight of birthwort root. The Chinese medicinal composition provided by the invention has the characteristics of good curative effect, high cure rate and low recurrence rate in treatment of mammary fibroma diseases.

The invention discloses a medicine for preventing and treating a gill rot disease of grass carps. The medicine is prepared from the following raw herbal materials: wintergreen barberry root, the tuber of stemona, cordate houttuynia, folium isatidis, Chinese gall, garlic, curcuma zedoary, kuh-seng, sculellaria barbata, cogongrass rhizome, the root bark of white mulberry, white peony root and tilmicosin. The raw herbal materials can be compatible in a combined manner through antibacterial agents, so that an antibacterial effect and a preventing and treating effect of the medicine are improved, by compatibility, an effective preventing and treating effect is achieved, and Chinese herbal medicines capable of improving immune therapeutic effects are utilized in a compatible manner so as to effectively improve nonspecific immunity of the grass carps, and the using effect of the medicine is improved.

The invention discloses a breast nodule treatment medicine composition, which is prepared by active pharmaceutical ingredients: by weight, 400-700 parts of white paeony roots, 250-400 parts of snakegourd peel, 250-400 parts of rhizoma curcuma, 250-400 parts of rhizoma cyperi, 250-400 parts of green tangerine peel, 350-550 parts of Chinese angelica, 80-140 parts of scorpio, 350-550 parts of turtle shell, 250-400 parts of kelp, 400-700 parts of sculellaria barbata, 350-550 parts of selfheal and 350-550 parts of poria cocos. The medicine composition has good anti-inflammatory, analgesic, circulation promoting and stasis removing functions, and is capable of not only improving pathological symptoms of proliferation of mammary gland effectively but inhibiting precancerous lesion of breast cancer, and accordingly a new pharmacy choice is provided for clinical treatment of proliferation of mammary gland and prevention of breast cancer.

The invention discloses a traditional Chinese medicine preparation with an antitumor effect. The traditional Chinese medicine preparation is prepared from the following raw materials in parts by weight: 20-80 parts of oldenlandia diffusa, 20-60 parts of sculellaria barbata, 1-10 parts of radix aconiti preparata, 10-60 parts of girald daphne bark, 1-10 parts of venenum bufonis, 20-60 parts of edible tulip, 20-40 parts of salviae miltiorrhizae, 20-40 parts of sophora flower bud, 10-40 parts of lucid ganoderma, 10-50 parts of polygonatum kingianum, 10-40 parts of gorgon fruits, 10-40 parts of poria cocos, 20-60 parts of Chinese yam, 10-30 parts of radix sophorae flavescentis, 10-40 parts of rhizoma dioscoreae nipponicae, 10-45 parts of radix achyranthis bidentatae and 20-60 parts of acanthopanax roots. According to the traditional Chinese medicine preparation disclosed by the invention, traditional Chinese medicines are matched and combined into a formula based on the treatment theory in the syndrome differentiation according to the traditional Chinese medicine theory; medication is rigorous and scientific; an experiment result proves that the traditional Chinese medicine preparation has good effects of inhibiting tumor cell growth and prompting tumor cell apoptosis, has a relatively high killing effect on a plurality of tumor cells, and has the effects of strengthening the body resistance, culturing the source and prompting immunologic functions.

The invention discloses a pollution-free sterilizing agent capable of preventing and treating a trunk blight disease of waxberries. The pollution-free sterilizing agent is prepared from the following components of radix puerariae, flos chrysanthemi indici, semen plantaginis, radices sileris, linseed, scutellaria barbata and folium artemisiae argyi. The pollution-free sterilizing agent capable of preventing and treating the trunk blight disease of the waxberries, disclosed by the invention, has the advantages that the source of raw materials is rich, and the cost is low; the pollution-free sterilizing agent is prepared by adopting natural components and is not only toxicity-free and pollution-free, but also capable of preventing and treating the trunk blight disease of the waxberries.

The invention discloses a capsule for eliminating an illness and removing stasis and a preparation method thereof. Manis pentadactyla, semen momordicae and edible tulip have the effects of invigorating blood circulation, removing stasis, eliminating illness and removing stasis, and directly guiding blood to lesions by main channels; curcuma zedoary, radix curcumae, toosendan fruit, felwort, moutan bark, immature bitter orange, pericarpium citri reticulatae viride, lysimachia christinae hance, radices trichosanthis and seed of job's tears have the effects of soothing the liver, regulating the flow of vital energy, clearing away heat and toxic materials, diminishing inflammation, promoting dieresis, balancing internal organs, and moderating yin and yang; rheum officinale, asarum and rhizoma alismatis have the effects of clearing toxins, regulating vital energy and blood, and dredging the six hollow organs; radix sophorae flavescentis and sculellaria barbata have the effects of diminishing inflammation, promoting dieresis and resisting tumors; therefore, all the components are used together to achieve the effects of promoting blood circulation to remove blood stasis, eliminating illness, removing stasis, clearing away heat and toxic materials, soothing the liver, regulating the flow of vital energy, smoothing internal organs, and resisting inflammation and tumors. Therefore, the capsule has a definite treatment effect on mastopathy, hyperplasia of mammary glands, a stomachache, a breast distending pain, adenomyosis of uterus, ovarian cyst, pelvic inflammation and annexitis; the recovery rate can be over 90%.

The invention relates to the technical field of medicine, in particular to a Eight-jewel elixir haemorrhoids ointment and a preparation method thereof. The Eight-jewel elixir haemorrhoids ointment comprises Eight-jewel elixir powder, pearl powder, amber, borneol, callicarpa bodinieri, scutellaria barbata and the like added with auxiliary materials including octadecanol, liquid paraffin, glyceryl monostearate, albolene, sodium dodecyl sulfate, glycerin and the like. The Eight-jewel elixir haemorrhoids ointment is an ideal dosage form for treating haemorrhoids, is simple and convenient to use, has better anti-inflammation, analgesic and hemostasis functions as well as certain health care function, can be applied to family standing and is particularly suitable for self-treatment.

The invention discloses a medicine for treating intestinal obstruction of infants and a preparation method thereof. The medicine comprises the following raw herbal materials: Chinese buckeye seeds, securidaca inappendiculata, tender catchweed bedstraw, helicteres isora, calophyllum membranaceum, jasminum laurifolium, portulaca oleracea, fructus cannabis, pericarpium arecae, edible fat made from milk, vernonia andersonii, stephania longa, orobanche coerulescens, fruit of highland barley malt, ixeris denticulata, pericarpium citri reticulatae viride, fructus aurantii, patrinia heterophylla, eretmochelys imbricata, rumexpatientia, scutellaria barbata, crotalaria tetragona, sida szechuensis, tuber or root of smilax stans, semen cassia, olibanum, astilbe chinensis, breynia fruticosa, perilla fruit, vigna umbellata, angelica sinensis, euonymus phellomana, red peony root and buckwheat. The medicine has the benefits as follows: the medicine has the efficacy of regulating qi, removing stasis, activating blood, moistening the intestines and relieving dyspepsia, meanwhile, has the effects of clearing heat, cooling blood, guiding qi downwards, removing intestinal obstruction, and resisting infection, and has the advantages of quick action, high improvement rate, definite curative effect, short treatment course, no toxic or side effect, low cost and the like.

The invention provides a lung-heat-clearing pharmaceutical composition and a preparation and extraction process thereof. The lung-heat-clearing pharmaceutical composition can be used for treating pulmonary fibrosis. The pharmaceutical composition is prepared from the following components: solanum nigrum, lily bulb, selfheal, thunberg fritillary bulb, paris polyphylla, prepared rhizoma polygonati,adenophora stricta, sculellaria barbata and oldenlandia diffusa, and can be prepared into an oral liquid form. A fingerprint spectrum is prepared from chlorogenic acid, caffeic acid, p-coumaric acid,scutellarin, rosmarinic acid and apigenin; the contents of peiminine and peiminine are detected, the transfer rates of the eight effective components are used as evaluation indexes to investigate thepreparation process, and the preferable extraction process comprises the following steps of soaking the medicinal materials for 1 hour, extracting twice with water of 8 times of volume or 50% ethanol,and extracting for 1.5 hours each time. The transfer rate reaches 120% or above, and the paste yield is 30%.

The invention relates to a health-protection prescription for a cancer patient, and belongs to the technical field of health protection of cancer patients. The prescription comprises the following components of 5 to 10 parts of gecko, 3 to 8 parts of centipede, 5 to 8 parts of leech, 1 to 5 parts of scorpion, 3 to 8 parts of sangusis draconis, 2 to 8 parts of semen brassicae, 1 to 5 parts of dandelion, 3 to 8 parts of hedyotis diffusa, 2 to 5 parts of crude trogopterus dung, 2 to 4 parts of crude ipomoea cairica, 1 to 3 parts of crude cyperus rotundus, 3 to 5 parts of crude costus root, 2 to 5 parts of radix actinidiae chinensis, 1 to 3 parts of nightshade, 4 to 8 parts of pteris multifda poir, 2 to 5 parts of solanum lyratum, 3 to 6 parts of sculellaria barbata, and 2 to 5 parts of mock strawberry. The health-protection prescription adopts a traditional Chinese medicine formula according to the characteristics of the cancer patient, has the effects of curing and gastrointestinal cancer and malignant tumor and protecting after curing, has a good therapeutic effect and good health protection effect, and is free of toxic and side effect and low in cost.

The invention relates to a compound traditional Chinese medicine preparation for treating primary hepatocellular carcinoma and portal vein tumor thrombus. The preparation is prepared from the following 13 medicinal materials by weight: scutellaria baicalensis, astragalus membranaceus, turmeric, pollen typhae, glossy privet fruits, leeches, semen coicis, sculellaria barbata, oldenlandia diffusa, bupleurum marginatum, oriental wormwood, fructus aurantii and liquorice. The preparation can be used for positively treating liver cancer by inhibiting diffusion, transfer and development of liver cancer and positively preventing generation and formation of portal vein tumor thrombus at the same time as well as ablating the portal vein tumor thrombus formed. In the preparation process, natural characteristics of all components of some traditional Chinese medicine power are maintained to the greatest extent and heavy metals and pesticide residues are removed to the maximum extent. The preparation further has a relaxation effect to pain of liver cancer.

The invention relates to a health formula for patients with lung cancer, belonging to the technical field of health of patients with cancer. The formula is prepared from the following components: 5-10 parts of geckos, 3-8 parts of centipede, 5-8 parts of leeches, 1-5 parts of scorpio, 3-8 parts of sangusis draconis, 2-8 parts of semen brassicae, 1-5 parts of dandelion, 2-4 parts of raw silene adenantha franch, 1-3 parts of raw cyperus rotundus, 3-5 parts of raw costus roots, 2-5 parts of Chinese actinidia roots, 1-3 parts of nightshade, 4-8 parts of phoenix-tail fern, 2-5 parts of solanum lyratum, 3-6 parts of sculellaria barbata and 2-5 parts of Indian strawberries. According to characteristics of the patients with lung cancer, the traditional Chinese medicine formula has the effects of curing and protecting gastric and intestinal cancers and malignant tumors, is good in curative effect, has a good health effect, and is free from toxic and side effects and low in cost.

The invention provides a pharmaceutical composition for treating primary liver cancer. The pharmaceutical composition comprises independently packaged powder and decoction, wherein the powder is prepared from the following components in parts by weight: 9 parts of pine pollen and 2-4 parts of cordyceps sinensis; the decoction is prepared from the following components in parts by weight: 6-9 partsof Bark of Common Anneslea, 15 parts of paris polyphylla, 18 parts of oldenlandia diffusa, 15 parts of sculellaria barbata, 12 parts of rhizoma smilacis glabrae, 15 parts of rhizoma sparganii, 15 parts of curcuma zedoary, 12 parts of eclipta alba and 0.5-1 part of venenum bufonis; the mass ratio of the powder to the decoction is 11-13: 108.5-112. The pharmaceutical composition provided by the invention is used for treating 886 patients with primary liver cancer, and the curative ratio is up to more than 83%, with 739 cases of cured, with 98 cases of improvement and 49 cases of ineffectiveness.

The invention relates to a traditional Chinese medicine formula, in particular to a medicine formula for treating leukemia. The formula comprises 27-33 parts by mass of astragalus membranaceus, 25-35 parts by mass of lucid ganoderma, 12-18 parts by mass of poria cocos, 12-18 parts by mass of Chinese yam, 12-18 parts by mass of edible tulip, 8-12 parts by mass of paris polyphylla, 12-18 parts by mass of selfheal, 25-35 parts by mass of oldenlandia diffusa and 25-35 parts by mass of sculellaria barbata. The medicine formula for treating leukemia disclosed by the invention has an obvious effect on leukemia treatment.